Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Stewart's Newest Discretionary Denial Has Attys On Edge No Photo Available

Dani Kass

The acting U.S. Patent and Trademark Office director's decision on Friday to reject patent challenges due to the petitioner's long-sta... (more story)

Healthcare Deals This Week: Omada, Antares, Amplify No Photo Available

Yeji Jesse Lee

The healthcare industry saw a few notable deals this past week, including a much-anticipated IPO from digital health company Omada and... (more story)

23andMe Auction Is A Wake-Up Call For Data Privacy Law No Photo Available

Yeji Jesse Lee

With its giant trove of customer genetic and health data up for auction, direct-to-consumer genetic testing company 23andMe's bankrupt... (more story)